These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Price MO; Price FW Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes. Javadi MA; Feizi S; Karbasian A; Rastegarpour A Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763 [TBL] [Abstract][Full Text] [Related]
4. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients]. Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial. Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783 [TBL] [Abstract][Full Text] [Related]
6. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%. Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142 [TBL] [Abstract][Full Text] [Related]
7. [Penetrating keratoplasty in high-risk children: prevention of graft rejection]. Pleskova AV; Khvatova AV Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116 [TBL] [Abstract][Full Text] [Related]
8. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Rao SN Am J Ophthalmol; 2006 Apr; 141(4):771-2. PubMed ID: 16564829 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts. Unal M; Yücel I Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A in perforating keratoplasty. Sundmacher R; Reinhard T Cesk Slov Oftalmol; 1995 Oct; 51(5):271-6. PubMed ID: 8948156 [TBL] [Abstract][Full Text] [Related]
11. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651 [TBL] [Abstract][Full Text] [Related]
12. Topical cyclosporin: a treatment for corneal graft rejection. Ross AH; Cook SD Clin Exp Ophthalmol; 2008 Jul; 36(5):399-400. PubMed ID: 18925911 [No Abstract] [Full Text] [Related]
13. Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer. Sonmez B; Beden U; Erkan D Int Ophthalmol; 2009 Apr; 29(2):123-5. PubMed ID: 18094939 [TBL] [Abstract][Full Text] [Related]
14. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis. Perry HD; Doshi SJ; Donnenfeld ED; Bai GS Cornea; 2002 Mar; 21(2):161-3. PubMed ID: 11862086 [TBL] [Abstract][Full Text] [Related]